Market revenue in 2023 | USD 1,107.1 million |
Market revenue in 2030 | USD 1,716.6 million |
Growth rate | 6.5% (CAGR from 2023 to 2030) |
Largest segment | Synthetic |
Fastest growing segment | Biotech |
Historical data | 2018 - 2022 |
Base year | 2023 |
Forecast period | 2024 - 2030 |
Quantitative units | Revenue in USD million |
Market segmentation | Synthetic, Biotech |
Key market players worldwide | Dr. Reddy’s Laboratories, Sun Pharmaceutical Industries, Teva Pharmaceutical Industries Ltd, Cipla Ltd DR, AbbVie Inc, Aurobindo Pharma, Sandoz Group AG Registered Shares, Viatris Inc, Fresenius Kabi |
No credit card required*
Name | Profile | # Employees | HQ | Website |
---|
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to active pharmaceutical ingredients market will help companies and investors design strategic landscapes.
Synthetic was the largest segment with a revenue share of 69.8% in 2023. Horizon Databook has segmented the Denmark active pharmaceutical ingredients market based on synthetic, biotech covering the revenue growth of each sub-segment from 2018 to 2030.
Denmark’s biotech and pharma industry is one of the most innovative markets globally. It is a leader in drug development and offers attractive business solutions for international business companies.
Companies are involved in Research & Development (R&D) collaborations and several strategic alliances with research organizations & universities for faster approval or development of products in Europe. Denmark conducts the highest number of clinical trials per capita globally.
The country has over 160 biotech companies, with 40,000 people employed in this industry, of which more than 5,000 are dedicated R&D employees. There are over 300 biotech service providers, with 8 universities and 4 major university hospitals. Key players in the market include Lundbeck: Novo Nordisk; Alk-Abelló; Leo Pharma; Bavarian Nordic; and Genmab.
Horizon Databook provides a detailed overview of country-level data and insights on the Denmark active pharmaceutical ingredients market , including forecasts for subscribers. This country databook contains high-level insights into Denmark active pharmaceutical ingredients market from 2018 to 2030, including revenue numbers, major trends, and company profiles.
No related regions found.
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account